Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.1086/367541
Twittear
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Martínez, José A. | - |
dc.contributor.author | Horcajada, Juan P. | - |
dc.contributor.author | Almela, Manuel | - |
dc.contributor.author | Marco, Francesc | - |
dc.contributor.author | Soriano, Alex | - |
dc.contributor.author | García-Vázquez, Elisa | - |
dc.contributor.author | Marco, Maria Ángeles | - |
dc.contributor.author | Torres, Antoni | - |
dc.contributor.author | Mensa, Josep | - |
dc.contributor.other | Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Medicina Interna | es |
dc.date.accessioned | 2024-07-02T10:28:36Z | - |
dc.date.available | 2024-07-02T10:28:36Z | - |
dc.date.issued | 2003-01-31 | - |
dc.identifier.citation | Clinical Infectious Diseases. 2003, 36 (4): 389–395 | es |
dc.identifier.issn | Print: 1058-4838 | - |
dc.identifier.issn | Electronic: 1537-6591 | - |
dc.identifier.uri | http://hdl.handle.net/10201/142804 | - |
dc.description | ©2003 by the Infectious Diseases Society of America. All rights reserved. This document is the Published, version of a Published Work that appeared in final form in Clinical Infectious Diseases . To access the final edited and published work see https://doi.org/10.1086/367541 | es |
dc.description.abstract | To assess the association between inclusion of a macrolide in a b-lactam–based empirical antibiotic regimen and mortality among patients with bacteremic pneumococcal pneumonia, 10 years of data from a database were analyzed. The total available set of putative prognostic factors was subjected to stepwise logistic regression, with in-hospital death as the dependent variable. Of the 409 patients analyzed, 238 (58%) received a b-lactam plus a macrolide and 171 (42%) received a b-lactam without a macrolide. Multivariate analysis revealed 4 variables to be independently associated with death: shock ( ), age of 65 years ( ), infectionsP ! .0001 P .02 with pathogens that have resistance to both penicillin and erythromycin ( ), and no inclusion of aP p .04 macrolide in the initial antibiotic regimen ( ). For patients with bacteremic pneumococcal pneumonia,P p .03 not adding a macrolide to a b-lactam–based initial antibiotic regimen is an independent predictor of inhospital mortality. However, only a randomized study can definitively determine whether this association is due to a real effect of macrolides. | es |
dc.format | application/pdf | es |
dc.format.extent | 7 | es |
dc.language | eng | es |
dc.publisher | Oxford University Press | es |
dc.relation | Sin financiación externa a la Universidad | es |
dc.rights | info:eu-repo/semantics/embargoedAccess | es |
dc.title | Addition of a macrolide to a b-Lactam–Based empirical antibiotic regimen Is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia | es |
dc.type | info:eu-repo/semantics/article | es |
dc.relation.publisherversion | https://academic.oup.com/cid/article/36/4/389/437900 | es |
dc.embargo.terms | Si | - |
dc.identifier.doi | https://doi.org/10.1086/367541 | - |
Aparece en las colecciones: | Artículos: Medicina |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Addition of a Macrolide to a b-Lactam–Based.....pdf | 99,1 kB | Adobe PDF | Visualizar/Abrir Solicitar una copia |
Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.